Part D Redesign: MedPAC Finalizes Recommendations To Congress But COVID-19 Will Get In The Way

 
• By Cathy Kelly
  
Pills
MedPAC Aims To Tamp Down Specialty Drug Costs In Part D
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet